New research has found weightlossdrug Wegovy can produce significant results for at least four years of treatment. The drug has also been found to deliver cardiovascular benefits in ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
In the semaglutide group, weightloss continued to week 65 and was sustained for 4years, with participants' losing on average 10.2% of their body weight and 7.7cm from their waistline, ...
The blockbuster weight-lossdrug Wegovy can help people sustain their weight-loss triumphs for several years and also may provide cardiovascular benefits, according to two new analyses of ...
Opinions expressed by Forbes Contributors are their own. I write about healthcare policy, with an emphasis on Rx drugs. Copenhagen, Denmark: Packages of the weightlossdrug "Wegovy" from the ...
Some results have been hidden because they may be inaccessible to you